Loading...
•
Sep 30, 2025
Option Care Health Q3 2025 Earnings Report
Option Care Health reported its financial results for the third quarter ended September 30, 2025.
Key Takeaways
Option Care Health delivered a strong third quarter with net revenue increasing by 12.2% year-over-year to $1.435 billion. While net income saw a slight decrease of 3.8%, adjusted diluted EPS grew by 9.8% to $0.45, and adjusted EBITDA increased by 3.4% to $119.5 million, demonstrating balanced growth and operational strength.
Net revenue increased by 12.2% year-over-year, reaching $1,435.0 million.
Adjusted diluted earnings per share grew by 9.8% to $0.45.
Adjusted EBITDA increased by 3.4% to $119.5 million.
The company repurchased $62.5 million of stock during the quarter.
Forward Guidance
For the full year 2025, Option Care Health updated its financial guidance, expecting net revenue between $5.60 billion and $5.65 billion, adjusted diluted EPS between $1.68 and $1.72, and adjusted EBITDA between $468 million and $473 million. Cash flow from operations is projected to be at least $320 million.
Positive Outlook
- Expected net revenue of $5.60 billion to $5.65 billion for full year 2025.
- Anticipated adjusted diluted EPS of $1.68 to $1.72 for full year 2025.
- Projected adjusted EBITDA of $468 million to $473 million for full year 2025.
- Expected cash flow from operations of at least $320 million for full year 2025.
- Effective tax rate of 25% to 27%.
Challenges Ahead
- Net interest expense of approximately $55 million to $57 million, indicating ongoing debt servicing costs.
- The guidance does not explicitly mention specific growth targets for net income, focusing more on adjusted metrics.
- No specific negative forward-looking statements were provided in the report.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...